Costamare Inc. (NYSE:CMRE) is now up 40.63% compared to a 12-month low of $5.07. We have seen the price to move -2.6% lower and get settled at $7.13 on Friday. At recent session, it appeared stuck in a range of $7.11 to $7.37. This company shares are 10.52% off its target price of $7.88 and the current market capitalization stands at $750.5M. The recent change has given its price a -0.03% deficit over SMA 50 and -31.77% deficit over its 52-week high. The stock witnessed 4.24% gains, 3.48% gains and 16.12% gains for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found CMRE’s volatility during a week at 3.55% and during a month it has been found around 3.93%.

Costamare Inc. (CMRE) Top Holders

Institutional investors currently hold around $130 million or 17.8% in CMRE stock. Look at its top three institutional owners. Morgan Stanley owns $14.32 million in Costamare Inc., which represents roughly 1.91% of the company’s market cap and approximately 11.02% of the institutional ownership. Similar statistics are true for the second largest owner, Global X Management Co Llc, which owns 1,423,733 shares of the stock are valued at $10.42 million. The third largest holder is Blackrock Inc., which currently holds $9.67 million worth of this stock and that ownership represents nearly 1.29% of its market capitalization.

Costamare Inc. 13F Filings

At the end of March 2017 reporting period, 59 institutional holders increased their position in Costamare Inc. (NYSE:CMRE) by some 5,646,268 shares, 56 decreased positions by 3,255,392 and 17 held positions by 8,856,509. That puts total institutional holdings at 17,758,169 shares, according to SEC filings. The stock grabbed 22 new institutional investments totaling 3,152,435 shares while 28 institutional investors sold out their entire positions totaling 1,280,575 shares.

Costamare Inc. (CMRE) Analyst Guide

Several analysts have released their opinion on Costamare Inc. (NYSE:CMRE), with 2 analysts believing it is a strong buy. Whereas 2 of them predict the stock is a hold. Also, there are 1 buy, 0 sell and 0 strong sell ratings, collectively assigning a 1.9 average brokerage recommendation.

Previous articlePengrowth Energy Corporation (PGH): A Detailed Look at its Institutional Ownership
Next articleBiocept, Inc. (BIOC) now has -55.16 deficit over its 52-week high